Compare CVS Health Corp (CVS) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Lucid Group Inc — how do they compare? CVS Health Corp trades at $104.88 (market cap $135.48B), while Lucid Group Inc trades at $4.42 (market cap $1.80B). The key difference: CVS Health Corp is far larger — about 75.3× Lucid Group Inc's market cap, and CVS Health Corp pays a 2.51% dividend while Lucid Group Inc pays none. Which is the better fit depends on your goals.
| CVS | LCID | |
|---|---|---|
Market Cap | $135.48B | $1.80B |
Sector | Health | Consumer Cyclical |
52-Week High | $106.18 | $31.30 |
52-Week Low | $58.75 | $4.62 |
Enterprise Value | $202.02B | $4.27B |
Dividend Yield | 2.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Lucid Group (LCID) trades at $5.51, down 0.72% amid significant volatility following bankruptcy rumors that the company denied on July 14, 2026. The stock shows bearish technical signals with negative financial metrics including a -239.81% net income margin and consistent earnings misses. Recent news highlights restructuring advisory engagement and multiple class-action lawsuits filed against the company, creating substantial investor uncertainty.
The outlook remains highly speculative with severe fundamental challenges including massive losses, negative cash flow, and declining revenue. While analyst consensus targets $10.50, representing 91% upside, the overwhelming hold/sell ratings and ongoing legal pressures suggest significant downside risk. Investment requires high risk tolerance given the company's financial distress and competitive EV market pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
